This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (102)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in JAMA  Topic Collections  • Men's Health, Other  • Randomized Controlled Trial  • Alert me on articles by topic

A Randomized Controlled Trial

Douglas S. King, PhD; Rick L. Sharp, PhD; Matthew D. Vukovich, PhD; Gregory A. Brown, MS; Tracy A. Reifenrath, MS; Nathaniel L. Uhl; Kerry A. Parsons, MS

JAMA. 1999;281:2020-2028.

Context  Androstenedione, a precursor to testosterone, is marketed to increase blood testosterone concentrations as a natural alternative to anabolic steroid use. However, whether androstenedione actually increases blood testosterone levels or produces anabolic androgenic effects is not known.

Objectives  To determine if short- and long-term oral androstenedione supplementation in men increases serum testosterone levels and skeletal muscle fiber size and strength and to examine its effect on blood lipids and markers of liver function.

Design and Setting  Eight-week randomized controlled trial conducted between February and June 1998.

Participants  Thirty healthy, normotestosterogenic men (aged 19-29 years) not taking any nutritional supplements or androgenic-anabolic steroids or engaged in resistance training.

Interventions  Twenty subjects performed 8 weeks of whole-body resistance training. During weeks 1, 2, 4, 5, 7, and 8, the men were randomized to either androstenedione, 300 mg/d (n=10), or placebo (n=10). The effect of a single 100-mg androstenedione dose on serum testosterone and estrogen concentrations was determined in 10 men.

Main Outcome Measures  Changes in serum testosterone and estrogen concentrations, muscle strength, muscle fiber cross-sectional area, body composition, blood lipids, and liver transaminase activities based on assessments before and after short- and long-term androstenedione administration.

Results  Serum free and total testosterone concentrations were not affected by short- or long-term androstenedione administration. Serum estradiol concentration (mean [SEM]) was higher (P<.05) in the androstenedione group after 2 (310 [20] pmol/L), 5 (300 [30] pmol/L), and 8 (280 [20] pmol/L) weeks compared with presupplementation values (220 [20] pmol/L). The serum estrone concentration was significantly higher (P<.05) after 2 (153 [12] pmol/L) and 5 (142 [15] pmol/L) weeks of androstenedione supplementation compared with baseline (106 [11] pmol/L). Knee extension strength increased significantly (P<.05) and similarly in the placebo (770 [55] N vs 1095 [52] N) and androstenedione (717 [46] N vs 1024 [57] N) groups. The increase of the mean cross-sectional area of type 2 muscle fibers was also similar in androstenedione (4703 [471] vs 5307 [604] mm²; P<.05) and placebo (5271 [485] vs 5728 [451] mm²; P<.05) groups. The significant (P<.05) increases in lean body mass and decreases in fat mass were also not different in the androstenedione and placebo groups. In the androstenedione group, the serum high-density lipoprotein cholesterol concentration was reduced after 2 weeks (1.09 [0.08] mmol/L [42 (3) mg/dL] vs 0.96 [0.08] mmol/L [37 (3) mg/dL]; P<.05) and remained low after 5 and 8 weeks of training and supplementation.

Conclusions  Androstenedione supplementation does not increase serum testosterone concentrations or enhance skeletal muscle adaptations to resistance training in normotestosterogenic young men and may result in adverse health consequences.

Author Affiliations: Exercise Biochemistry Laboratory, Department of Health and Human Performance, Iowa State University, Ames (Drs King, Sharp, and Vukovich, Messrs Brown and Uhl, and Mss Reifenrath and Parsons); and Experimental and Applied Sciences, Golden, Colo (Dr Vukovich).

RELATED LETTER

Effects of Androstenedione in Young Men
Robert Palusinski, Wojciech Barud, Tadhg O'Gara, Karlis Ullis, Tim N. Ziegenfuss, Richard Cohen, William D. Brink, William J. Roberts, Douglas S. King, Rick L. Sharp, Gregory A. Brown, and Matthew D. Vukovich
JAMA. 2000;283(6):741-743.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Medical, Legal, and Societal Implications of Androstenedione Use
Charles E. Yesalis III
JAMA. 1999;281(21):2043-2044.
EXTRACT | FULL TEXT  

June 2, 1999
JAMA. 1999;281(21):2057-2058.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ulnar Deep Venous Thrombosis in a Professional Baseball Pitcher: A Case Report
Hurbanek et al.
Am J Sports Med 2007;35:2131-2134.
FULL TEXT  

Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study
Kvorning et al.
Am. J. Physiol. Endocrinol. Metab. 2006;291:E1325-E1332.
ABSTRACT | FULL TEXT  

QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY
Schrader et al.
Drug Metab. Dispos. 2006;34:1328-1335.
ABSTRACT | FULL TEXT  

Popular Ergogenic Drugs and Supplements in Young Athletes
Calfee and Fadale
Pediatrics 2006;117:e577-e589.
ABSTRACT | FULL TEXT  

Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements
Hougaku et al.
Am. J. Physiol. Endocrinol. Metab. 2006;290:E234-E242.
ABSTRACT | FULL TEXT  

{Delta}-4-Androstene-3,17-Dione Binds Androgen Receptor, Promotes Myogenesis in Vitro, and Increases Serum Testosterone Levels, Fat-Free Mass, and Muscle Strength in Hypogonadal Men
Jasuja et al.
J. Clin. Endocrinol. Metab. 2005;90:855-863.
ABSTRACT | FULL TEXT  

Effects of Oral Administration of Androstenedione on Plasma Androgens in Young Women Using Hormonal Contraception
Bassindale et al.
J. Clin. Endocrinol. Metab. 2004;89:6030-6038.
ABSTRACT | FULL TEXT  

Urinary Excretion of Steroid Metabolites after Chronic Androstenedione Ingestion
Brown et al.
J. Clin. Endocrinol. Metab. 2004;89:6235-6238.
ABSTRACT | FULL TEXT  

Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports
Tokish et al.
Am J Sports Med 2004;32:1543-1553.
ABSTRACT | FULL TEXT  

Asynchronous Bilateral Achilles Tendon Ruptures and Androstenediol Use
Battista et al.
Am J Sports Med 2003;31:1007-1009.
FULL TEXT  

Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men
Beckham and Earnest
Br. J. Sports. Med. 2003;37:212-218.
ABSTRACT | FULL TEXT  

Use and Effectiveness of Performance-Enhancing Substances
Boyce
Journal of Pharmacy Practice 2003;16:22-36.
ABSTRACT  

Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis
Nissen and Sharp
J. Appl. Physiol. 2003;94:651-659.
ABSTRACT | FULL TEXT  

Effect of Androstenedione Ingestion on Plasma Testosterone in Young Women; a Dietary Supplement with Potential Health Risks
Kicman et al.
Clin. Chem. 2003;49:167-169.
FULL TEXT  

Effects of Oral Androstenedione Administration on Serum Testosterone and Estradiol Levels in Postmenopausal Women
Leder et al.
J. Clin. Endocrinol. Metab. 2002;87:5449-5454.
ABSTRACT | FULL TEXT  

Endocrine and Lipid Responses to Chronic Androstenediol-Herbal Supplementation in 30 to 58 Year Old Men
Brown et al.
J. Am. Coll. Nutr. 2002;20:520-528.
ABSTRACT | FULL TEXT  

Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
Ripp et al.
Drug Metab. Dispos. 2002;30:570-575.
ABSTRACT | FULL TEXT  

Acute hormonal response to sublingual androstenediol intake in young men
Brown et al.
J. Appl. Physiol. 2002;92:142-146.
ABSTRACT | FULL TEXT  

Anabolic Steroids
Kuhn
Recent Prog Horm Res 2002;57:411-434.
ABSTRACT | FULL TEXT  

Metabolism of Orally Administered Androstenedione in Young Men
Leder et al.
J. Clin. Endocrinol. Metab. 2001;86:3654-3658.
ABSTRACT | FULL TEXT  

Use of Ergogenic Aids by Athletes
Silver
J Am Acad Orthop Surg 2001;9:61-70.
ABSTRACT | FULL TEXT  

The Andro Project: Physiological and Hormonal Influences of Androstenedione Supplementation in Men 35 to 65 Years Old Participating in a High-Intensity Resistance Training Program
Broeder et al.
Arch Intern Med 2000;160:3093-3104.
ABSTRACT | FULL TEXT  

Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men
Brown et al.
J. Clin. Endocrinol. Metab. 2000;85:4074-4080.
ABSTRACT | FULL TEXT  

Effects of Androstenedione in Young Men
Palusinski et al.
JAMA 2000;283:741-743.
FULL TEXT  

Oral Androstenedione Administration and Serum Testosterone Concentrations in Young Men
Leder et al.
JAMA 2000;283:779-782.
ABSTRACT | FULL TEXT  

Androstenedione Does Not Stimulate Muscle Protein Anabolism in Young Healthy Men
Rasmussen et al.
J. Clin. Endocrinol. Metab. 2000;85:55-59.
ABSTRACT | FULL TEXT  

Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men
Brown et al.
J. Appl. Physiol. 1999;87:2274-2283.
ABSTRACT | FULL TEXT  

Anabolic Interventions for Aging-Associated Sarcopenia
Bross et al.
J. Clin. Endocrinol. Metab. 1999;84:3420-3430.
FULL TEXT  

Androstenedione Supplementation: Harm Without Benefit
Journal Watch Dermatology 1999;1999:20-20.
FULL TEXT  

Androstenedione Supplementation: Harm Without Benefit
JWatch General 1999;1999:4-4.
FULL TEXT  

Medical, Legal, and Societal Implications of Androstenedione Use
Yesalis III
JAMA 1999;281:2043-2044.
FULL TEXT